tiprankstipranks
Advertisement
Advertisement
Cytek Biosciences Balances Growth Momentum With Cost Pressures
PremiumCompany AnnouncementsCytek Biosciences Balances Growth Momentum With Cost Pressures
1M ago
Cytek Maintained at Hold as Risk‑Reward Stays Balanced; $5 Price Target Reaffirmed
Premium
Ratings
Cytek Maintained at Hold as Risk‑Reward Stays Balanced; $5 Price Target Reaffirmed
1M ago
Cytek Biosciences Balances Growth With Margin Strain
Premium
Company Announcements
Cytek Biosciences Balances Growth With Margin Strain
3M ago
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth
PremiumCompany AnnouncementsCytek Biosciences Earnings Call: Mixed Sentiment and Growth
7M ago
Cytek Biosciences Reports Modest Revenue Growth in Q3 2025
Premium
Company Announcements
Cytek Biosciences Reports Modest Revenue Growth in Q3 2025
7M ago
Cautious Hold on Cytek Biosciences Amid Market Stagnation and Growth Uncertainty
Premium
Ratings
Cautious Hold on Cytek Biosciences Amid Market Stagnation and Growth Uncertainty
7M ago
Cytek Biosciences Earnings Call Reveals Mixed Outlook
PremiumCompany AnnouncementsCytek Biosciences Earnings Call Reveals Mixed Outlook
10M ago
Cytek Biosciences: Q2 2025 Financial Performance Overview
Premium
Company Announcements
Cytek Biosciences: Q2 2025 Financial Performance Overview
10M ago
Cytek Biosciences Faces Market Challenges and Uncertain Growth Prospects Leading to Hold Rating
Premium
Ratings
Cytek Biosciences Faces Market Challenges and Uncertain Growth Prospects Leading to Hold Rating
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100